Table 3.
In vitro BBB model | Decreased transendothelial resistance (TEER)1,2 |
Increased leakage of FITC-Dextran, Evans Blue, and toxins1,2,3,4,5,6 | |
Increased transmigration of peripheral blood mononuclear cells (PBMCs) and expression of adhesion molecules4,7,8,9,10 | |
Decreased expression of zona occludin 1(ZO-1), junctional adhesion molecule 2 (JAM-2), and other tight junction proteins1,2,5,7,8 | |
Increased expression of pro-inflammatory cytokines3,10,11 | |
Rodent models | Increased leakage of Evans Blue and NaFl5,12 |
Increased edema13,14 | |
Increased transmigration of leukocytes and expression of adhesion molecules13,15 | |
Decreased expression of zona occludin 1 (ZO-1)5 | |
Clinical studies | Increased penetration of peripheral viruses like HIV16 |
Increased transmigration of leukocytes and expression of adhesion molecules17 |
1Fiala et al. (2005); 2Gandhi et al. (2010); 3Zhang et al. (1998); 4Fiala et al. (1998); 5Yao et al. (2011); 6Fiala et al. (1996); 7Fiala et al. (2008); 8Dhillon et al. (2008); 9Nair et al. (2004); 10Gan et al. (1999); 11Lee et al. (2001); 12Yao et al. (2011); 13Barroso-Moguel et al. (1997); 14Sharma et al. (2009); 15Chang et al. (2000); 16Nath et al. (2001); 17Buch et al. (2011).